# Impact of Delta Model of End Stage Liver Disease (MELD) in High MELD Liver Transplant Recipients

> **NCT07570901** · — · COMPLETED · sponsor: **University of Jena** · enrollment: 446 (actual)

## Conditions studied

- Liver Disease (Alcoholic or Not)
- Liver Transplantation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07570901
- **Lead sponsor:** University of Jena
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 446 (ACTUAL)
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07570901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07570901, "Impact of Delta Model of End Stage Liver Disease (MELD) in High MELD Liver Transplant Recipients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07570901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*